- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02869334
Remediation of Auditory Recognition in Schizophrenia With tDCS
June 16, 2021 updated by: Daniel C. Javitt, New York State Psychiatric Institute
Remediation of Auditory Recognition in Schizophrenia With Transcranial Direct Current Stimulation (tDCS)
The purpose of this study is to determine whether transcranial direct current stimulation (tDCS), when combined with different forms of computer based training, improves the ability to discriminate small differences between sounds in people diagnosed with schizophrenia or schizoaffective disorder.
Study Overview
Status
Completed
Conditions
Detailed Description
This study uses an experimental procedure called transcranial direct current stimulation (tDCS).
Little is known about how tDCS affects the brain or why some people diagnosed with schizophrenia or schizoaffective disorder have trouble with certain kinds of hearing.
This study is being done to see if an experimental computer training program, when combined with tDCS, can help people to hear better.
In tDCS, a small amount of electricity is passed through electrodes placed on the head that is able to stimulate the brain.
By stimulating the brain, the investigators believe that the functioning of the brain can be altered.
This study will test whether such stimulation of the brain, when done with computer training, can improve hearing ability and if this improvement helps in other ways, like detecting changes in someone's tone of voice or understanding other people's emotions better.
The data being collected aims to better understand how the brain processes sounds and how tDCS affects the brain.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- New York State Psychiatric Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18-55
- Primary diagnosis of Schizophrenia or schizoaffective disorder
- English fluency
- Willing/capable to provide informed consent
- Auditory tone matching deficits
- Receiving stable doses of antipsychotic medication(s) for at least 2 weeks
- IQ>75
Exclusion Criteria:
- Serious neurological disorder or medical condition/ treatment known to affect the brain. Neurological Disorder that affects the central nervous system (CNS), such as epilepsy, neurodegenerative disorders, movement disorders and sensory disorders.
- Current or past history (within the last 6 months) of substance abuse or dependence (excluding nicotine)
- Pregnancy or breastfeeding
- Taking anticholinergic medication (e.g. Cogentin, Thorazine, Clozaril, thioridazine)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Auditory remediation with active tDCS
Auditory remediation program paired with active transcranial direct current stimulation (tDCS) for 30 minutes, 2-3 sessions per week
|
Active tDCS, where an extremely weak electric current passes through the brain
Computer program designed to improve discrimination between sounds
|
|
Experimental: Auditory remediation with sham tDCS
Auditory remediation program paired with sham transcranial direct current stimulation (tDCS) for 30 minutes, 2-3 sessions per week
|
Computer program designed to improve discrimination between sounds
Sham (inactive or placebo) tDCS
|
|
Sham Comparator: Control (computer games with sham tDCS)
Non-remediation, control computer activities (e.g.
games) with sham transcranial direct current stimulation (tDCS) for 30 minutes, 2-3 sessions per week
|
Sham (inactive or placebo) tDCS
Computer program (e.g.
games), which are not designed to improve discrimination between sounds
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Auditory Tone Matching Task
Time Frame: Change in performance from Baseline at completion of training (week 16)
|
Ability to match tones following brief delay
|
Change in performance from Baseline at completion of training (week 16)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Auditory Emotion Recognition (AER) Task
Time Frame: Change in performance from Baseline at completion of training (week 16)
|
Ability to detect emotion based on tone of voice
|
Change in performance from Baseline at completion of training (week 16)
|
|
ER-40
Time Frame: Change in performance from Baseline at completion of training (week 16)
|
Penn Emotion Recognition Test-40 Faces Version
|
Change in performance from Baseline at completion of training (week 16)
|
|
The Awareness of Social Inference Test (TASIT)
Time Frame: Change in performance from Baseline at completion of training (week 16)
|
The TASIT is a measure of social cognition, theory of mind as reflected in the ability to detect lies/sarcasm while viewing social vignettes.
Total scores range from 0-100% correct.
Higher numbers (positive change) are considered better.
|
Change in performance from Baseline at completion of training (week 16)
|
|
Auditory Mismatch Negativity (MMN)
Time Frame: Change in performance from Baseline at completion of training (week 16)
|
Change in event related potentials (ERP) acquired during a task of auditory mismatch negativity (MMN), assessed with electroencephalography (EEG)
|
Change in performance from Baseline at completion of training (week 16)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Daniel Javitt, MD, PhD, NY State Psychiatric Institute, Columbia University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
January 31, 2020
Study Completion (Actual)
January 31, 2020
Study Registration Dates
First Submitted
July 19, 2016
First Submitted That Met QC Criteria
August 11, 2016
First Posted (Estimate)
August 16, 2016
Study Record Updates
Last Update Posted (Actual)
July 8, 2021
Last Update Submitted That Met QC Criteria
June 16, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7266
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Recruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
Bradley LegaRecruiting
Clinical Trials on Active Transcranial direct current stimulation (tDCS)
-
Manhattan Psychiatric CenterCompletedSchizophrenia | Auditory HallucinationUnited States
-
ElsanRecruitingCancer Pain | Refractory PainFrance
-
D'Or Institute for Research and EducationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted
-
Centre Hospitalier St AnneNot yet recruiting
-
NYU Langone HealthNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingDepressionUnited States
-
Minneapolis Veterans Affairs Medical CenterThe Defense and Veterans Brain Injury Center; Center for Veterans Research... and other collaboratorsActive, not recruitingTraumatic Brain Injury | ImpulsivityUnited States
-
United States Army Aeromedical Research LaboratoryCompletedTranscranial Direct Current StimulationUnited States
-
Washington University School of MedicineCompletedAnxiety | Depressive Symptoms | Cognitive Impairment, MildUnited States
-
Federal University of São PauloSpaulding Rehabilitation HospitalCompletedChronic Pain | Osteoarthritis, KneeBrazil
-
University of BernRecruiting